Cite
HARVARD Citation
Arango, C. et al. (2022). Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries. Lancet. pp. 113-124. [Online].